Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?

× No keyword cloud information.

17 in total

1. Long-acting thyroid stimulator and related factors.

Authors: P Kendall-Taylor; S M Dirmikis; D S Munro
Journal: Proc R Soc Med Date: 1975-04

Review 2. The pathogenesis of Graves' disease and Hashimoto's thyroiditis.

Authors: R Volpé; N R Farid; C Von Westarp; V V Row
Journal: Clin Endocrinol (Oxf) Date: 1974-07 Impact factor: 3.478

3. Binding of thyroid stimulators to thyroid membranes.

Authors: B R Smith; R Hall
Journal: FEBS Lett Date: 1974-06-15 Impact factor: 4.124

4. Quantitative thyroid scanning: a reliable thyroid function test.

Authors: L B Arkles
Journal: Am J Roentgenol Radium Ther Nucl Med Date: 1974-08

5. Sequential assessment during drug treatment of thyrotoxicosis.

Authors: W D Alexander; D G McLarty; P Horton; A D Pharmakiotis
Journal: Clin Endocrinol (Oxf) Date: 1973-01 Impact factor: 3.478

6. Thyroid-stimulating immunoglobulins and the control of thyroid function.

Authors: R Clague; E D Mukhtar; G A Pyle; J Nutt; F Clark; M Scott; D Evered; B R Smith; R Hall
Journal: J Clin Endocrinol Metab Date: 1976-09 Impact factor: 5.958

7. Evidence of lower toxicity during thyroxine suppression after a single 3-mg L-thyroxine dose: comparison to the classical L-triiodothyronine test for thyroid suppressibility.

Authors: K W Wenzel; H Meinhold
Journal: J Clin Endocrinol Metab Date: 1974-05 Impact factor: 5.958

8. Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.

Authors: E D Mukhtar; B R Smith; G A Pyle; R Hall; P Vice
Journal: Lancet Date: 1975-03-29 Impact factor: 79.321

9. Short-term antithyroid drug therapy for the thyrotoxicosis of Graves's disease.

Authors: M A Greer; H Kammer; D J Bouma
Journal: N Engl J Med Date: 1977-07-28 Impact factor: 91.245

10. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease.

Authors: T F Davies; P P Yeo; D C Evered; F Clark; B R Smith; R Hall
Journal: Lancet Date: 1977-06-04 Impact factor: 79.321

11 in total

1. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.

Authors: Y Mori; N Matoba; S Miura; N Sakai; Y Taira
Journal: World J Surg Date: 1992 Jul-Aug Impact factor: 3.352

2. Thyroglobulin, thyrotropin and thyrotropin binding inhibiting immunoglobulins assayed at the withdrawal of antithyroid drug therapy as predictors of relapse of Graves' disease within one year.

Authors: J N Talbot; F Duron; R Féron; P Aubert; G Milhaud
Journal: J Endocrinol Invest Date: 1989-10 Impact factor: 4.256

3. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

Authors: J Ginsberg; C von Westarp
Journal: CMAJ Date: 1986-05-15 Impact factor: 8.262

Review 4. [Cell receptor defects as the cause of endocrine and metabolic diseases (author's transl)].

Authors: W Gerok
Journal: Klin Wochenschr Date: 1979-06-15

5. Interference of thyroglobulin in TSab detection by radio-receptor assay.

Authors: G F Fenzi; L Bartalena; E Macchia; F Monzani; M Checchi
Journal: J Endocrinol Invest Date: 1979 Apr-Jun Impact factor: 4.256

6. Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.

Authors: R Hörmann; B Saller; R Müller; K Mann
Journal: Klin Wochenschr Date: 1985-12-16

7. 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).

Authors: J Hensen; P Kotulla; R Finke; K Badenhoop; K Koppenhagen; H Meinhold; H Schleusener
Journal: J Endocrinol Invest Date: 1984-06 Impact factor: 4.256

8. Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis.

Authors: P Dandona; N J Marshall; S P Bidey; A Nathan; C W Havard
Journal: Br Med J Date: 1979-02-10

9. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.

Authors: H Bliddal; K Bech; K Siersbaek-Nielsen; T Friis
Journal: J Endocrinol Invest Date: 1983-08 Impact factor: 4.256

10. Thyroid-stimulating antibodies in patients with long-term remission of Graves' hyperthyroidism.

Authors: R Hörmann; A Hobelsberger; B Saller; K Mann
Journal: Klin Wochenschr Date: 1986-10-31